Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Kin Meds vs NP2GO

Kin Meds
Graded #73

Lower grade

vs+7.299999999999997
NP2GO
Graded #37

Higher grade

The verdict

NP2GO takes it — 80.2/100 to 72.9/100.

NP2GO grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Both molecules across 40 states, but upper-mid pricing and no verification listing.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNP2GO +7
74
81
Dose & formulationKin Meds +13
93
80
Clinical oversightNP2GO +5
74
79
Labs & monitoringNP2GO +25
53
78
FulfillmentNP2GO +10
72
82
Contract termsNP2GO +27
55
82
Kin Meds · left barNP2GO · right bar

The numbers

MetricKin MedsNP2GO
WeighScore72.9/10080.2/100
GradeCB−
Scorecard rank#73#37
Semaglutide$149/mo (brand Wegovy)$150/mo
Tirzepatide$149/mo (brand Zepbound)$250/mo
CoverageCoverage not published40 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Kin Meds

Graded #73 · C

Strengths

  • Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
  • Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
  • LegitScript verified
  • Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
  • Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health

Where it loses points

  • Legal entity name and state of incorporation not publicly disclosed
  • The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
  • Per-state availability not listed
  • $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
  • Lab work and dose-titration support not clearly described
NP2GO

Graded #37 · B−

Strengths

  • Both molecules
  • 40-state footprint
  • Transparent listed pricing

Where it loses points

  • Not LegitScript-verified
  • Upper-mid pricing ($150/$250)
  • Not all 50 states

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard